Ping An Ventures is raising a total of $1.3bn for two life sciences-focused fund: $500m for a dollar-denominated fund and $800m for a renminbi-denominated one.
Ping An Ventures, the corporate venturing unit of China-based insurance group Ping An, is currently seeking to raise $1.3bn in capital for two healthcare-oriented funds. Both funds will invest at growth and pre-initial public offering stage businesses. The corporate venturing firm is aiming to pool between $300m and $500m for a dollar-denominated fund, and between RMB4bn and RMB5bn ($640m to $800m) for a renminbi-denominated fund.
Launched in 2012, Ping An Ventures has been investing in deals spanning across a wide…
